The Food and Drug Administration is taking steps to help consumers better know the exact identity of the fish they eat. Not name, date, and serial number, but pretty close. The new tool in its arsenal of weapons against fish fraud is DNA barcoding. The agency is installing sequencing equipment initially in nine of its major laboratories across the country, including one in the Washington area, and will eventually have the equipment in a dozen labs. These facilities will assess the DNA of at least 100 species of fish, making sure that tuna and snapper and grouper are just that and not some cheap—and potentially poisonous—substitute.
According to Douglas Karas of the FDA, this new technology, which went into use this month, is an opportunity for the agency to “put our enforcement muscle to work. What we hope is that greater enforcement will lead to greater compliance among people who aren’t doing it now.”
Karas says it’s tough to pinpoint the exact link in the chain where the fraud happens. It can be at any stage—the fisherman, the processor, the distributor, the wholesaler, the market, or even the restaurant. Is it greed, or ignorance, or both? “When the fish is first mislabeled, it is someone making a conscious choice. Often it is economically driven to avoid tariffs and to sell a cheaper species of fish.”
The consumer plays an important role in the process. “Much of the data that the FDA has on seafood substitution comes from consumer complaints, so it is primarily from the retail level,” Karas says.
If you think it can’t happen to you, the Boston Globe recently conducted a five-month study of fish served in restaurants, markets, and stores across Massachusetts. They collected 183 samples. Nearly half were mislabeled. Several years ago, a Chicago couple became seriously ill after they ate poison pufferfish that had been labeled as monkfish. Karas says this kind of incident is at the heart of what the FDA want to prevent.
The sequencing machines are expensive—published estimates are $150,000—and Karas says the lab analysis costs about $10 to 15 a fish. Most of the species will be screened at the “last stage before the consumer,” he adds. Eventually this technology could be in place at the supermarket. “There’s nothing that would preclude someone in the private sector who wants to test their seafood from doing it now. We can’t mandate that. It’s up to someone in the industry to make that decision.”
Perhaps it won’t be long before we order our fish not only by the pound but with its DNA certificate, too.
The FDA Is Cracking Down on Fish Fraud
A new method of identifying fish aims to protect against mislabeled fish.
The Food and Drug Administration is taking steps to help consumers better know the exact identity of the fish they eat. Not name, date, and serial number, but pretty close. The new tool in its arsenal of weapons against fish fraud is DNA barcoding. The agency is installing sequencing equipment initially in nine of its major laboratories across the country, including one in the Washington area, and will eventually have the equipment in a dozen labs. These facilities will assess the DNA of at least 100 species of fish, making sure that tuna and snapper and grouper are just that and not some cheap—and potentially poisonous—substitute.
According to Douglas Karas of the FDA, this new technology, which went into use this month, is an opportunity for the agency to “put our enforcement muscle to work. What we hope is that greater enforcement will lead to greater compliance among people who aren’t doing it now.”
Karas says it’s tough to pinpoint the exact link in the chain where the fraud happens. It can be at any stage—the fisherman, the processor, the distributor, the wholesaler, the market, or even the restaurant. Is it greed, or ignorance, or both? “When the fish is first mislabeled, it is someone making a conscious choice. Often it is economically driven to avoid tariffs and to sell a cheaper species of fish.”
The consumer plays an important role in the process. “Much of the data that the FDA has on seafood substitution comes from consumer complaints, so it is primarily from the retail level,” Karas says.
If you think it can’t happen to you, the Boston Globe recently conducted a five-month study of fish served in restaurants, markets, and stores across Massachusetts. They collected 183 samples. Nearly half were mislabeled. Several years ago, a Chicago couple became seriously ill after they ate poison pufferfish that had been labeled as monkfish. Karas says this kind of incident is at the heart of what the FDA want to prevent.
The sequencing machines are expensive—published estimates are $150,000—and Karas says the lab analysis costs about $10 to 15 a fish. Most of the species will be screened at the “last stage before the consumer,” he adds. Eventually this technology could be in place at the supermarket. “There’s nothing that would preclude someone in the private sector who wants to test their seafood from doing it now. We can’t mandate that. It’s up to someone in the industry to make that decision.”
Perhaps it won’t be long before we order our fish not only by the pound but with its DNA certificate, too.
Most Popular in News & Politics
See a Spotted Lanternfly? Here’s What to Do.
Meet DC’s 2025 Tech Titans
What Happens After We Die? These UVA Researchers Are Investigating It.
GOP Candidate Quits Virginia Race After Losing Federal Contracting Job, Trump Plans Crackdown on Left Following Kirk’s Death, and Theatre Week Starts Thursday
USDA Spent $16,400 on Banners to Honor Trump and Lincoln
Washingtonian Magazine
September Issue: Style Setters
View IssueSubscribe
Follow Us on Social
Follow Us on Social
Related
Why Can You Swim in the Seine but Not the Potomac River?
This DC Woman Might Owe You Money
Why a Lost DC Novel Is Getting New Attention
These Confusing Bands Aren’t Actually From DC
More from News & Politics
How to Pick a Good Title-and-Settlement Company in the DC Area
Weird Press Conference Ends Trump’s Vacation From Offering Medical Advice, Kimmel Goes Back to Work Tonight, and DC Man Arrested for Shining Laser Pointer at Marine One
Why Can You Swim in the Seine but Not the Potomac River?
Nominations Are Now Open for 500 Most Influential People List
Trump and Musk Reunite, Administration Will Claim Link Between Tylenol and Autism, and Foo Fighters Play Surprise Show in DC
This DC Woman Might Owe You Money
A New Exhibition Near the White House Takes a High-Tech Approach to a Fundamental Question: What Is the American Dream?
Want to See What Could Be Ovechkin’s Last Game in DC? It’s Going to Cost You.